NCT05650216 2022-12-14
Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）
Shanghai Chest Hospital
Phase 2 Unknown
Clinical Trials
12 trialsNCT05199649 2022-01-20
Correlation Between the Efficacy of Neoadjuvant Chemotherapy Combined With Immunotherapy of Operable Thoracic Esophageal Squamous Cell Carcinoma and the Metabolites of Intestinal Flora
The First Affiliated Hospital of Soochow University
Phase NA Unknown
NCT05174325 2021-12-30
Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05028231 2021-08-31
NICCE
Tongji Hospital
Unknown
NCT04275986 2021-07-07
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT04602013 2020-10-26
Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT04229537 2020-01-18
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
Sinocelltech Ltd.
Phase 1 Unknown
NCT03185988 2019-07-19
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System
Peking University
Phase 2 Unknown
NCT03833466 2019-02-15
ECMTPneo
Peking University
Phase 2 Unknown
NCT03579004 2018-07-06
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
Russian Academy of Medical Sciences
Phase 2 Unknown
NCT00002884 2013-08-07
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01402180 2011-07-26
Nimotuzumab
Fudan University
Phase 2/3 Unknown